Jim Cramer's Investment Insights: Stocks to Watch and Buy
On a recent episode of CNBC's “Mad Money Lightning Round,” renowned financial commentator Jim Cramer shared his thoughts on multiple stocks, offering valuable insights for investors looking to navigate the market.
Recommendations for Uber Technologies
Cramer expressed a favorable outlook on Uber Technologies, Inc. (NYSE: UBER), encouraging investors to consider buying more shares. Despite facing a recent downgrade from JMP Securities analyst Andrew Boone, who adjusted Uber from Market Outperform to Market Perform while maintaining a price target of $95, Cramer remains optimistic about the company's growth potential.
AES Corporation: A Solid Utility Investment
The financial expert also highlighted The AES Corporation (NYSE: AES), stating, “I think it's time to pick up that utility.” The company made headlines recently by increasing its quarterly dividend from 17.25 cents to 17.595 cents per share, signaling a commitment to returning value to shareholders.
PENN Entertainment's Market Performance
Turning to PENN Entertainment, Inc. (NASDAQ: PENN), Cramer noted a lack of enthusiasm. However, on December 13, JP Morgan upgraded the stock from Neutral to Overweight, raising its price target significantly from $19 to $27. This change reflects growing confidence in the company amidst a volatile market.
Nucor Corporation's Challenges
Cramer acknowledged the difficulties surrounding Nucor Corporation (NYSE: NUE), saying, “It's been very, very tough to own this great steel maker.” The company recently provided fourth-quarter guidance, projecting earnings per share (EPS) of 55 cents to 65 cents, which contrasts sharply with the consensus estimate of 86 cents, demonstrating the challenges ahead.
Lazard: A Hidden Gem
Notably, Cramer described Lazard, Inc. (NYSE: LAZ) as “really inexpensive,” suggesting it presents a compelling buying opportunity. However, on December 20, analyst Aidan Hall downgraded Lazard from Outperform to Market Perform, adjusting the price target from $65 to $57, indicating a cautious view on the stock's near-term performance.
Holding Steady with Eli Lilly
Cramer recommended holding onto shares of Eli Lilly and Company (NYSE: LLY), especially after the FDA approved Zepbound, a weight loss drug aimed at treating moderate-to-severe obstructive sleep apnea in adults with obesity. This development enhances Eli Lilly's growth trajectory in the pharmaceutical sector.
Labcorp's Position in the Healthcare Sector
Lastly, regarding Labcorp Holdings Inc (NYSE: LH), Cramer mentioned that the stock priced at 15 times earnings is acceptable, despite the general market's wariness towards healthcare stocks. Morgan Stanley analyst Ricky Goldwasser maintained Labcorp with an Overweight rating, increasing the price target from $260 to $270, demonstrating positive sentiment from some analysts.
Price Movement and Market Overview
The market has been volatile, impacting stock performance significantly:
- Uber shares increased by 4.7%, settling at $63.17.
- AES shares rose by 1.4% to close at $13.05.
- Penn Entertainment shares fell by 2.9%, settling at $19.24.
- Lazard shares decreased by 1.4% to settle at $50.74.
- Eli Lilly shares gained 0.8%, reaching $778.07.
- Nucor shares dropped by 1.9%, closing at $114.48.
- Labcorp shares fell by 0.5% to end at $228.19.
Frequently Asked Questions
What stocks did Jim Cramer recommend?
Jim Cramer recommended stocks including Uber, AES, and Lazard, highlighting their potential in the current market.
What is Jim Cramer's opinion on Uber?
Cramer remains optimistic about Uber, suggesting it is a good buying opportunity despite a recent downgrade.
Why did Cramer suggest buying AES Corporation?
Cramer believes AES is a solid utility investment, especially after its recent dividend increase.
What challenges is Nucor Corporation facing?
Nucor has provided challenging fourth-quarter guidance, reflecting difficulties in the current steel market.
What did Jim Cramer say about Lazard?
Cramer views Lazard as inexpensive and a good buying opportunity, despite recent downgrades from analysts.
